Table 7.
Overall | HR | p-Value | [95%CI] |
mEHT | 0.70 | 0.035 | 0.51–0.98 |
HIV-negative | 1.05 | 0.786 | 0.74–1.50 |
Age at Enrolment | 0.99 | 0.240 | 0.97–1.01 |
FIGO Stage | 0.98 | 0.913 | 0.70–1.37 |
FIGO Stage II | HR | p-Value | [95%CI] |
mEHT | 0.78 | 0.357 | 0.46–1.33 |
HIV-negative | 1.20 | 0.538 | 0.68-2.11 |
Age at Enrolment | 0.99 | 0.582 | 0.97–1.02 |
FIGO Stage III | HR | p-Value | [95%CI] |
mEHT | 0.66 | 0.040 | 0.43–0.98 |
HIV-negative | 0.98 | 0.932 | 0.62–1.55 |
Age at Enrolment | 0.99 | 0.278 | 0.97–1.01 |
Abbreviations: FIGO: Fédération Internationale de Gynécologie et d’Obstétrique; HIV: Human Immunodeficiency Virus; HR: Hazard Ratio; mEHT: Modulated Electro-Hyperthermia.